HUTCHMED (China) (HCM) Total Debt (2015 - 2025)
HUTCHMED (China)'s (HCM) quarterly Total Debt came in at $12.0 million in Q4 2025, up 12.46% year-on-year from $10.7 million in Q4 2024, and down 87.18% on a QoQ basis from $93.4 million in Q2 2025.
HUTCHMED (China) (HCM) Total Debt (2015 - 2025) Analysis & Trends
HUTCHMED (China) (HCM) has 11 years of Total Debt data on file, last reported at $12.0 million in Q4 2025.
- On a quarterly basis, Total Debt rose 12.46% year-over-year to $12.0 million in Q4 2025; TTM through Dec 2025 was $12.0 million, a 12.46% increase from a year earlier, with the FY2025 full-year figure at $12.0 million, up 12.87% from the prior year.
- Total Debt for Q4 2025 stood at $12.0 million, down from $93.4 million in the prior quarter.
- Over the last five years, Total Debt for HCM reached as high as $10.2 billion in Q4 2023 and fell as low as $418000.0 in Q2 2022.
- Historically, Total Debt has averaged $950.2 million across 5 years, with a median of $26.9 million in 2021.
- Across the five-year window, Total Debt soared 438655.81% in 2023 and slumped 99.9% in 2024, its largest moves.
- Year by year, Total Debt stood at $3.5 million in 2021, then slumped by 32.99% to $2.3 million in 2022, then surged by 438655.81% to $10.2 billion in 2023, then slumped by 99.9% to $10.7 million in 2024, then climbed by 12.46% to $12.0 million in 2025.
- Per Business Quant data, the three most recent Total Debt figures were $12.0 million in Q4 2025, $93.4 million in Q2 2025, and $10.7 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 11.45 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.63 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 28.76 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 7.15 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.34 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.81 Bn |
| 10 | HUTCHMED (China) | 241.90 Mn | 243.61 Mn | - | 11.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.98 Mn |
| Jun 30, 2025 | 93.44 Mn |
| Dec 31, 2024 | 10.65 Mn |
| Jun 30, 2024 | 82.10 Mn |
| Dec 31, 2023 | 10.15 Bn |
| Jun 30, 2023 | 40.15 Mn |
| Dec 31, 2022 | 2.31 Mn |
| Jun 30, 2022 | 418,000.00 |
| Dec 31, 2021 | 3.45 Mn |
| Jun 30, 2021 | 26.88 Mn |
| Mar 31, 2021 | 26.87 Mn |
| Dec 31, 2020 | 401,000.00 |
| Jun 30, 2020 | 26.84 Mn |
| Dec 31, 2019 | 366,000.00 |
| Mar 31, 2019 | 26.76 Mn |
| Dec 31, 2018 | 27.17 Mn |
| Jun 30, 2018 | 37.38 Mn |
| Dec 31, 2017 | 29.99 Mn |
| Jun 30, 2017 | 46.85 Mn |
| Dec 31, 2016 | 46.79 Mn |